Jun '25 • General discussion
Lilly News
Hope just became a little more affordable for those who insist on using branded only; though new prices may also compel the research world to lower their prices on tirz. as well.
Eli Lilly and Company's announcement today — offering Zepbound for $499/month or less for all dosages — is a welcome move for people living with obesity, a disease that has long been misunderstood and under-treated.
For many, this still won’t be affordable. But it’s a step in the right direction.
• Toward more accessible treatment.
• Toward less stigma in care.
• Toward recognizing lived experience in policy and practice.
We need continued momentum — from pricing reform to insurance coverage to changing how we talk about weight and health.
5
0 comments
Lilly News
skool.com/kristinas-peptide-junkies-24-4251
Advance your peptide research with precise, science-driven guidance, expert community talk, and access to vetted suppliers, promotions, and giveaways.
Leaderboard (30-day)
1
+24
2
+8
3
+7
4
+5
5
+4
Powered by